Skip to main content
logo
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.00
-0.36 (-3.17%)
Aug 13, 2026, 4:00 PM EDT - Market closed

MiNK Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.36-12.49-10.78-22.46-27.99-30.21
Depreciation & Amortization
0.150.180.220.20.120.08
Stock-Based Compensation
2.242.671.813.863.031.74
Other Adjustments
-0.320.42-1.26-0.27-2.7911.83
Changes in Accounts Payable
0.610.69-1.18-1.922.66-0.15
Changes in Accrued Expenses
0.60.72-0.392.033.42-0.07
Changes in Other Operating Activities
1.261.882.042.792.683.96
Operating Cash Flow
-6.83-5.93-9.56-15.76-18.87-12.83
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.07-0.25-0.25
Investing Cash Flow
----0.07-0.25-0.25

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--5--9.46
Long-Term Debt Repaid
-5-----
Net Long-Term Debt Issued (Repaid)
-5-5--9.46
Issuance of Common Stock
19.4114.95.820.07039.8
Repurchase of Common Stock
--0.17--0.48-0.16-
Net Common Stock Issued (Repurchased)
18.9914.725.82-0.41-0.1639.8
Financing Cash Flow
13.9914.7210.82-0.41-0.1649.26

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.03-0.01-0.05-0.030.020.02
Net Cash Flow
7.138.781.21-16.27-19.2536.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6.83-5.93-9.56-15.84-19.12-13.08
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.44-1.39-2.53-4.61-5.68-5.02
Levered Free Cash Flow
-13.75-9.02-5.11-19.43-19.35-17.19
Unlevered Free Cash Flow
-9.37-9.17-10.61-19.89-22.31-24.79
SEC Filings: 10-K · 10-Q